Arabic Arabic English English French French German German
dark

Bayer and Mammoth Biosciences to collaborate on novel gene editing technolog

BayerBayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, today announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Over 100 insurers sue Texas electric authority, utilities over 2021 winter storm damage

Next Post

New study finds high rates of trauma for mothers and babies from forceps and vacuum deliveries in Canada

Related Posts
Total
0
Share